Device Vigilance

Device Vigilance - Axcellant

Device Vigilance

  1. Feb 28, 2025

What Does ‘Device Vigilance’ Mean?

Device vigilance refers to the systematic monitoring and evaluation of medical devices after they have been placed on the market. It involves the collection, analysis, and interpretation of data related to the safety and performance of medical devices throughout their lifecycle.

The primary goal of device vigilance is to identify and mitigate potential risks associated with the use of medical devices. This process includes reporting adverse events, tracking device malfunctions, and implementing corrective actions to ensure patient safety and maintain the quality of healthcare delivery.

Why Is the ‘Device Vigilance’ Important in Clinical Research?

Device vigilance is crucial in clinical research as it ensures the ongoing safety and effectiveness of medical devices after they have been approved and released to the market. It provides a mechanism for researchers and healthcare professionals to continually assess and improve device performance based on real-world data and experiences.

In clinical trials, device vigilance helps researchers identify potential issues that may not have been apparent during initial testing phases. This information can inform future study designs, lead to product improvements, and ultimately enhance patient safety and treatment outcomes in clinical settings.

Good Practices and Procedures

  1. Implement a standardized adverse event reporting system with clear categorization and severity grading criteria
  2. Conduct regular post-market surveillance studies to proactively identify long-term device performance and safety trends
  3. Establish a cross-functional review board to assess vigilance data and recommend appropriate corrective actions
  4. Develop and maintain a comprehensive device history record, including software updates and component changes
  5. Conduct periodic user feedback surveys to capture qualitative data on device usability and potential issues

Related Terms

Resources

Large Language Models in Nuclear Cardiology: From Experimental Tools to Clinical Infrastructure

3 Questions with: Prof. Piotr Słomka Large language models are entering nuclear cardiology at a pace that makes the usual…

From Half-Life to Clinical Impact: Mastering Time-Critical Supply Chains

How Axcellant helped a diagnostic study overcome isotope supply, manufacturing, and logistics constraints In radiopharmaceutical development, we often say that…

How ACT EU Is Forcing a Global Approach to Trial Timelines

Europe’s clinical trials market is entering a more practical phase in its approach to competitiveness. With the Clinical Trials Regulation…